Related Experiment Video

Updated: Aug 18, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

Disseminated histoplasmosis in an AIDS patient treated with itraconazole

P D Kell1, D E Smith, S E Barton

  • 1Department of Genitourinary Medicine, St. Stephen's Clinic & Westminster Hospital.

Genitourinary Medicine
|August 1, 1991
PubMed

Insights

A patient with Acquired Immunodeficiency Syndrome (AIDS) experienced a disseminated Histoplasmosis infection, initially treated with itraconazole. Despite initial success, the patient relapsed during maintenance therapy, highlighting treatment challenges.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Immunocompromised Hosts

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) significantly impairs the immune system, increasing susceptibility to opportunistic infections.
  • Disseminated fungal infections pose a serious threat in patients with advanced HIV/AIDS.
  • Accurate and timely diagnosis of opportunistic infections is critical for effective management.

Observation:

  • A patient diagnosed with AIDS presented with symptoms suggestive of Pneumocystis pneumonia, including fever, shortness of breath, and productive cough.
  • Diagnostic investigations, including blood cultures and bone marrow examination, identified disseminated Histoplasmosis capsulatum infection.
  • The patient was initiated on itraconazole therapy, achieving initial clinical improvement.

Findings:

  • Disseminated Histoplasmosis capsulatum infection was confirmed in an AIDS patient.
  • Initial treatment with itraconazole led to temporary remission.
  • The patient experienced a relapse of disseminated Histoplasmosis while undergoing maintenance therapy.

Implications:

  • This case underscores the potential for severe, disseminated fungal infections like Histoplasmosis in individuals with AIDS.
  • Relapse during maintenance therapy suggests challenges in achieving sustained fungal clearance in immunocompromised patients.
  • Further research into optimal and prolonged treatment strategies for disseminated Histoplasmosis in AIDS patients is warranted.

More Related Videos

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...